Cephalon, Leo Pharmaceutical Products Ltd. deal

The companies agreed to develop regulators of gene transcription to treat neurological diseases. The project

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE